Sanofi (XSWX:SAN) Cash Flow for Dividends: CHF-4,476 Mil (TTM As of Dec. 2025)


XSWX:SAN Sanofi SA XSWX:SAN
87 GF Score
Price CHF73.20
GF Value CHF104.30
! 2 Warning Signs
View Full Analysis

What is Sanofi Cash Flow for Dividends?

Sanofi XSWX:SAN 87 Cash Flow for Dividends is CHF-4,476 Mil as of Dec. 2025. GuruFocus rates XSWX:SAN with a GF Score™ of 87/100 and a GF Value™ of CHF104.30. The stock has 2 warning signs investors should review.

Sanofi's cash flow for dividends for the six months ended in Dec. 2025 was CHF0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-4,476 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Sanofi's quarterly payment of dividends increased from Dec. 2024 (CHF0 Mil) to Jun. 2025 (CHF-4,476 Mil) but then declined from Jun. 2025 (CHF-4,476 Mil) to Dec. 2025 (CHF0 Mil).

Sanofi's annual payment of dividends increased from Dec. 2023 (CHF-4,200 Mil) to Dec. 2024 (CHF-4,392 Mil) and increased from Dec. 2024 (CHF-4,392 Mil) to Dec. 2025 (CHF-4,453 Mil).

Sanofi Cash Flow for Dividends Related Terms

Sanofi Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Sanofi's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sanofi Cash Flow for Dividends Chart

Sanofi Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,171.04 -4,113.25 -4,200.46 -4,391.71 -4,452.94

Sanofi Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -4,525.76 0.00 -4,475.88 0.00
XSWX:SAN
87GF Score
Sanofi SA XSWX:SAN
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sanofi Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-4,476 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of CHF-4,476 Mil mean?
Sanofi (XSWX:SAN) has a Cash Flow for Dividends of CHF-4,476 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Sanofi and its competitors.
Is Sanofi's Cash Flow for Dividends too high?
Sanofi's current Cash Flow for Dividends is CHF-4,476 Mil. Overall, Sanofi has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Sanofi's Cash Flow for Dividends compare to LLY and JNJ?
Sanofi's Cash Flow for Dividends of CHF-4,476 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Sanofi and its competitors. Sanofi's current Cash Flow for Dividends is CHF-4,476 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanofi stock overvalued right now?
Sanofi (XSWX:SAN) has a current Cash Flow for Dividends of CHF-4,476 Mil. The stock's GF Value™ is CHF104.30, compared to a current price of CHF73.20 — trading 29.8% below its estimated fair value. The current Cash Flow for Dividends is CHF-4,476 Mil. Sanofi's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Sanofi (XSWX:SAN), the current Cash Flow for Dividends is CHF-4,476 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sanofi (XSWX:SAN) Overvalued in 2026?

Based on GuruFocus' analysis, Sanofi stock appears to be undervalued. The current stock price of CHF73.20 is trading 29.8% below its estimated GF Value™ of CHF104.30.

Key valuation signals for XSWX:SAN:

  • Cash Flow for Dividends: CHF-4,476 Mil
  • GF Value™: CHF104.30 vs. price of CHF73.20 (29.8% below fair value)
  • GF Score™: 87/100 with 2 warning signs

No single metric tells the full story. See the XSWX:SAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sanofi Business Description

Address 46, Avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
87GF Score

Get the complete analysis for XSWX:SAN

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF73.20
Price
CHF104.30
GF Value